Beneficial Pleiotropic Effects of Statins

被引:0
作者
Lunder, Mojca [1 ,2 ]
Ziberna, Lovro [1 ]
Drevensek, Gorazd [1 ]
Sabovic, Miso [2 ]
机构
[1] Univ Ljubljani, Fak Med, Inst Farmakologijo & Eksperimentalno Toksikologij, Ljubljana 1000, Slovenia
[2] Univ Klin Ctr Ljubljana, Klin Oddelek Zilne Bolezni, Ljubljana 1000, Slovenia
来源
ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL | 2011年 / 80卷 / 01期
关键词
statins; beneficial pleiotropic effects; mechanism of action; cardiovascular system; other organ systems; COENZYME-A REDUCTASE; PERCUTANEOUS CORONARY INTERVENTION; BONE-MINERAL DENSITY; ISCHEMIC-REPERFUSED MYOCARDIUM; SYSTOLIC HEART-FAILURE; CHRONIC KIDNEY-DISEASE; MULTIPLE-SCLEROSIS; RANDOMIZED-TRIAL; ENDOTHELIAL DYSFUNCTION; PARKINSON DISEASE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Statins are recognised as the most effective lipid-lowering drugs. The main mechanism of action is the inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, which is a key enzyme in the cholesterol synthesis pathway Statins also have additional effects, known as pleiotropic effects, which are mostly due to the inhibition of the formation of non-steroidal isoprenoids. The latter have important functions in the activation of many intracellular signalling pathways. Consequently, statins improve endothelial function, have anti-inflammatory and immunomodulatory activity, act as antioxidants, stabilize atherosclerotic plaques and influence haemostasis and thrombosis. The described mechanisms are particularly relevant in the protective activity of statins on the cardiovascular system, central nervous system, kidneys and many other organs. Conclusions: In the current article we review the pharmacological mechanisms of action, which contribute to the beneficial pleiotropic effects of statins. Described mechanisms are supported by the evidence obtained from clinical trials in the last decade.
引用
收藏
页码:39 / 49
页数:11
相关论文
共 131 条
  • [1] Simvastatin Alleviates Myocardial Contractile Dysfunction and Lethal Ischemic Injury in Rat Heart Independent of Cholesterol-Lowering Effects
    Adameova, A.
    Harcarova, A.
    Matejikova, J.
    Pancza, D.
    Kuzelova, M.
    Carnicka, S.
    Svec, P.
    Bartekova, M.
    Styk, J.
    Ravingerova, T.
    [J]. PHYSIOLOGICAL RESEARCH, 2009, 58 (03) : 449 - 452
  • [2] Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin
    Aktas, O
    Waiczies, S
    Smorodchenko, A
    Dörr, J
    Seeger, B
    Prozorovski, T
    Sallach, S
    Endres, M
    Brocke, S
    Nitsch, R
    Zipp, F
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (06) : 725 - 733
  • [3] Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study
    Albert, MA
    Danielson, E
    Rifai, N
    Ridker, PM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01): : 64 - 70
  • [4] Prior statin therapy is associated with a decreased rate of severe sepsis
    Almog, Y
    Shefer, A
    Novack, V
    Maimon, N
    Barski, L
    Eizinger, M
    Friger, M
    Zeller, L
    Danon, A
    [J]. CIRCULATION, 2004, 110 (07) : 880 - 885
  • [5] Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial by Stroke Subtypes
    Amarenco, Pierre
    Benavente, Oscar
    Goldstein, Larry B.
    Callahan, Alfred, III
    Sillesen, Henrik
    Hennerici, Michael G.
    Gilbert, Steve
    Rudolph, Amy E.
    Simunovic, Lisa
    Zivin, Justin A.
    Welch, K. Michael A.
    [J]. STROKE, 2009, 40 (04) : 1405 - 1409
  • [6] Arnaud Claire, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P127, DOI 10.2174/1568006043586198
  • [7] Relative Risks for Stroke by Age, Sex, and Population Based on Follow-Up of 18 European Populations in the MORGAM Project
    Asplund, Kjell
    Karvanen, Juha
    Giampaoli, Simona
    Jousilahti, Pekka
    Niemela, Matti
    Broda, Grazyna
    Cesana, Giancarlo
    Dallongeville, Jean
    Ducimetriere, Pierre
    Evans, Alun
    Ferrieres, Jean
    Haas, Bernadette
    Jorgensen, Torben
    Tamosiunas, Abdonas
    Vanuzzo, Diego
    Wiklund, Per-Gunnar
    Yarnell, John
    Kuulasmaa, Kari
    Kulathinal, Sangita
    [J]. STROKE, 2009, 40 (07) : 2319 - 2326
  • [8] Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography - A study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden
    Ballantyne, Christie M.
    Raichlen, Joel S.
    Nicholls, Stephen J.
    Erbel, Raimund
    Tardif, Jean-Claude
    Brener, Sorin J.
    Cain, Valerie A.
    Nissen, Steven E.
    [J]. CIRCULATION, 2008, 117 (19) : 2458 - 2466
  • [9] Use of statins and the risk of Parkinson's disease - A retrospective case-control study in the UK
    Becker, Claudia
    Jick, Susan S.
    Meier, Christoph R.
    [J]. DRUG SAFETY, 2008, 31 (05) : 399 - 407
  • [10] Becker C, 2009, EXPERT OPIN DRUG SAF, V8, P261, DOI [10.1517/14740330902859956, 10.1517/14740330902859956 ]